Cargando…

Anti Xa activity after high dose LMWH thrombosis prophylaxis in covid 19 patients at the intensive care unit

INTRODUCTION: Coagulopathy in Coronavirus disease 2019 (covid-19) has been demonstrated by an increase in D-dimer, prothrombin time (PT), fibrinogen and factor VIII. Venous thromboembolic events are a common abnormality in patients with covid-19. We evaluate the results of intensive care unit (ICU)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlot, E.A., Van den Dool, E.J., Hackeng, C.M., Sohne, M., Noordzij, P.G., Van Dongen, E.P.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2020
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374121/ https://www.ncbi.nlm.nih.gov/pubmed/32805623 http://dx.doi.org/10.1016/j.thromres.2020.07.035

Ejemplares similares

Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
por: Torres-Machorro, Adriana, et al.
Publicado: (2020)

D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19
por: Stawiarski, Kristin, et al.
Publicado: (2021)

The effect of renal impairment and obesity on anti-Xa peak and trough levels in patients receiving therapeutic doses of nadroparin: a comparison with control patients
por: Mast, L., et al.
Publicado: (2023)

Effect of dexamethasone on direct Xa-inhibitor oral anticoagulant plasma levels in patients with COVID-19
por: Bosch, Floris T.M., et al.
Publicado: (2021)

Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery
por: Wei, Qingqing, et al.
Publicado: (2023)

Coagulopathy monitoring and anticoagulation management in COVID-19 patients on ECMO: Advantages of a heparin anti-Xa-based titration strategy
por: Rhoades, Ruben, et al.
Publicado: (2021)

Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy
por: Lawlor, Matthew, et al.
Publicado: (2021)

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection
por: Trunfio, Mattia, et al.
Publicado: (2020)

In situ immune-mediated pulmonary artery thrombosis and Covid-19 pneumonitis
por: Mandal, Amit K.J., et al.
Publicado: (2021)

COVID-19 associated pulmonary thrombosis
por: van Nieuwkoop, C.
Publicado: (2020)

Coronavirus disease 2019 is associated with catheter-related thrombosis in critically ill patients: A multicenter case-control study
por: Smit, Jasper M., et al.
Publicado: (2021)

Portal vein thrombosis in a patient with COVID-19
por: Franco-Moreno, A., et al.
Publicado: (2020)

COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic
por: Parks, Anna L., et al.
Publicado: (2020)

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022)

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
por: van Haaps, Thijs F., et al.
Publicado: (2021)

The long haul COVID-19 arterial thrombosis
por: Borrelli, Maria Pia, et al.
Publicado: (2022)

Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: A propensity score-matched analysis
por: Moll, Matthew, et al.
Publicado: (2021)

The effectiveness and safety of LMWH for preventing thrombosis in patients with spinal cord injury: a meta-analysis
por: Lin, Ze, et al.
Publicado: (2021)

Does Intraoperative Fibrinogen Affect Blood Loss or Transfusion Practice After Aortic Arch Surgery: A Prematurely Ended Randomized Trial
por: Vlot, Eline A., et al.
Publicado: (2022)

Cerebral venous thrombosis and thrombocytopenia post-COVID-19 vaccination
por: Franchini, Massimo, et al.
Publicado: (2021)

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020)

Thrombosis post COVID-19 vaccinations: Potential link to ACE pathways
por: Dalan, Rinkoo, et al.
Publicado: (2021)

Association of Plasma Fibrinogen and Thromboelastography With Blood Loss in Complex Cardiac Surgery
por: Vlot, Eline A., et al.
Publicado: (2021)

Impact of blood type on thrombosis and disease severity in adult COVID-19 patients()
por: Rao, Shivani, et al.
Publicado: (2021)

Safety of COVID-19 vaccination in patients with previous cerebral venous sinus thrombosis
por: Gil-Díaz, Aída, et al.
Publicado: (2022)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

Treatment of Deep Vein Thrombosis with Continuous IV Infusion of LMWH: A Retrospective Study in 32 Children
por: Fiamoli, Veronika, et al.
Publicado: (2011)

COVID-19 and Diarrhoea: the Therapeutic Role OF LMWH
por: Dioscoridi, Lorenzo, et al.
Publicado: (2021)

In situ pulmonary thrombosis in patients with COVID-19 pneumonia: different phenotypes may exist
por: Wang, Lan, et al.
Publicado: (2020)

COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy
por: Daughety, Molly M., et al.
Publicado: (2020)

Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury
por: Eck, R. J., et al.
Publicado: (2022)

Systematic screening for pulmonary embolism using the YEARS algorithm in patients with suspected COVID-19 in the Emergency Department
por: Luu, Inge H.Y., et al.
Publicado: (2021)

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing
por: Willemsen, Laura M., et al.
Publicado: (2021)

Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg
por: Pizzolo, Francesca, et al.
Publicado: (2020)

Continuous administration of LMWH in critical patients: a contribution to the monitoring of hemocoagulation
por: Stach, Z, et al.
Publicado: (2006)

Fatal intracranial hemorrhage in patient with thrombocytopenia and positive HIT antibodies after vaccination with ChAdOx1 nCoV-19 - VITT without thrombosis?
por: Medić, Marijana Grgić, et al.
Publicado: (2022)

Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres
por: Motlekar, Nusrat, et al.
Publicado: (2009)

The Efficacy of Tripterygium Glycosides Combined with LMWH in Treatment of HSPN in Children
por: Jin, Yan, et al.
Publicado: (2021)

Invited commentary to: ADAMTS13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19 by Tiffany Pascreau et al. Letter to the Editors-in-Chief, Thrombosis Research
por: Lämmle, Bernhard, et al.
Publicado: (2021)

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
por: Beenen, L.F.M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sdr48msrjun9kr3mat5u7055pa